🇺🇸 FDA
Pipeline program

ChAdOx1-HBV

HBV-003

Phase 2 mab completed

Quick answer

ChAdOx1-HBV for Chronic Hepatitis B is a Phase 2 program (mab) at Barinthus Biotherapeutics plc. with 1 ClinicalTrials.gov record(s).

Program details

Company
Barinthus Biotherapeutics plc.
Indication
Chronic Hepatitis B
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials